« Back to Record
Citation APA

Bonnefoi, H., MacGrogan, G., Poncet, C., Iggo, R., Pommeret, F., Grellety, T., Larsimont, D., Becette, V., Kerdraon, O., Bibeau, F., Ghnassia, J. P., Picquenot, J. M., Thomas, J., Tille, J. C., Slaets, L., Bodmer, A., Bergh, J., & Cameron, D. A. (2019). Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. British Journal of Cancer, 120(9), 913-921. doi:10.1038/s41416-019-0420-y


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/287282

Bonnefoi, H., MacGrogan, G., Poncet, C., Iggo, R., Pommeret, F., Grellety, T., Larsimont, D., Becette, V., Kerdraon, O., Bibeau, F., Ghnassia, J. P., Picquenot, J. M., Thomas, J., Tille, J. C., Slaets, L., Bodmer, A., Bergh, J., & Cameron, D. A. (2019). Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. British Journal of Cancer, 120(9), 913-921. doi:10.1038/s41416-019-0420-y